Comprehensive Clinical Care and Critical Pathophysiology Notes

Sepsis, Clinical Prioritization, and Hemodynamic Stability

• Sepsis Recognition and Prioritization: Early recognition is paramount for survival. The protocol for assessment follows the sequence: Airway (A), Breathing (B), Circulation (C), Blood Pressure (BP), and Antibiotics (AB).
• Assessment Priorities:     * Hypotension and Perfusion: Immediate evaluation of ABCs followed by determining whether the condition is Acute vs. Chronic. Key indicators include Temperature and Respiratory Rate (RR).     * The Biggest Threat: Sudden clinical changes, unexpected findings, new symptoms, or post-operative complications.     * Vitals Signs and Testing: Abnormal blood cultures and altered vitals are critical. Clinical interventions include Broad-spectrum Antibiotics, IV Fluids, and Vasopressors.
• Prioritization Frameworks:     * Expected vs. Unexpected: Prioritize patients with sudden, unexpected changes over those with expected chronic manifestations.     * Maslow’s Hierarchy of Needs: Priorities follow the order: Physiological needs → Safety → Love and Belonging → Esteem → Self-Actualization.
• Acute Management Actions:     * Organ Failure and Shock: Require immediate resuscitation and the ABCs protocol.     * Interventions: Gain IV access for Isotonic fluids and Vasopressors. Continuous monitoring is required for Lactate levels, Arterial Blood Gases (ABGs), Complete Blood Count (CBC), and Comprehensive Metabolic Panel (CMP).     * Identify Shock Type: Distinguish between Hypovolemic (requires fluids and blood) and Septic shock (requires fluids and antibiotics).

Critical Laboratory Values and Diagnostic Evaluation

• Potassium ($K$): Normal range is $3.5 - 5.0\,mEq/L$.     * Levels below $3.0$ can lead to lethal arrhythmias.     * Levels at or above $6.0$ indicate high risk for cardiac arrest.
• Sodium ($Na$): Normal range is $135 - 145\,mEq/L$.     * Severe risks including seizures and coma occur if levels drop to or below $120$ or rise to or above $160$.
• Lactate: Baseline levels are $0.5 - 2.2\,mmol/L$. A level $\geq 4\,mmol/L$ is diagnostic for Sepsis.
• Coagulation and Electrolytes:     * INR: Therapeutic range is typically $2 - 3$.     * Calcium ($Ca$): $8.5 - 10.5\,mg/dL$. Low levels cause tetany; high levels increase cardiac contractility but can cause seizures.     * Magnesium ($Mg$): $1.5 - 2.5\,mEq/L$. Low levels cause arrhythmias and seizures.     * aPTT: $25 - 35\,seconds$.
• Renal and Metabolic Markers:     * Creatinine: $0.6 - 1.3\,mg/dL$.     * BUN: $7 - 20\,mg/dL$.

Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS)

• Diabetic Ketoacidosis (DKA):     * Pathophysiology: Little to no insulin is present. The body breaks down fat for energy, leading to Ketones and Metabolic Acidosis. Characterized by massive dehydration and electrolyte loss.     * Clinical Presentation: Glucose levels between $250 - 600\,mg/dL$, Kussamaul respirations (deep, rapid breathing), fruity breath, and abdominal pain. Primarily affects Type 1 Diabetes.     * DKA Management Sequence:         1. Fluids first.         2. Assess Potassium ($K$). Acidosis causes $K$ to shift out of cells. If $K < 3.3$, HOLD insulin. If $K$ is between $3.5 - 5.0$, give $K$ with Insulin.         3. Administer IV Insulin.         4. Monitor Glucose, Potassium, and ABGs. When Glucose reaches $200\,mg/dL$, add Dextrose to fluids to prevent hypoglycemia.
• Hyperosmolar Hyperglycemic State (HHS):     * Pathophysiology: Some insulin is present, preventing ketone formation (no acidosis), but allows extreme Hyperglycemia ($> 600\,mg/dL$).     * Clinical Presentation: Massive dehydration and significant neurological changes. Primarily affects Type 2 Diabetes.     * HHS Management:         1. Fluids (Priority).         2. Cautious Insulin administration.         3. Constant monitoring of neurological status and electrolytes.

Renal Pathophysiology and Management: AKI, RRT, and Transplant

• Acute Kidney Injury (AKI):     * Management Focus: Maintain perfusion, manage fluid balance (Goal Urine Output (UOP) of $0.5\,mL/kg/hr$), and monitor vitals (Mean Arterial Pressure/MAP). Evaluate Cr, BUN, and electrolytes.     * Etiologies: Prerenal causes include Hypotension, Shock, Dehydration, burns, and Sepsis. Avoid nephrotoxins.
• Renal Replacement Therapy (RRT):     * Indications for RRT: Uremia (pericarditis, cognitive changes), Hyperkalemia ($> 6.5$), severe acidosis ($pH < 7.1$), and fluid overload.     * Continuous RRT (CRRT): Indicated for ICU patients with hypotension who cannot tolerate regular Dialysis. Provides slow, gentle dialysis with fewer BP changes to manage severe fluid overload.
• Renal Transplant Complications and Renal Arterial Disease:     * Rejection: Treated with immunosuppressants. Hyperacute rejection (minutes to hours) requires immediate removal. Acute rejection (weeks to months) presents with sudden UOP drops and organ dysfunction. Chronic rejection (months to years) is managed supportively.     * Renal Artery Issues: Thrombosis (leads to graft failure), Stenosis (causes HTN), and Infections.

Burn Resuscitation and Critical Integumentary Care

• Parkland Formula for Fluid Resuscitation:     * Formula: $4\,mL \times \text{kg} \times \text{\%TBSA (Total Burn Surface Area)}$.     * Timing: Administer $1/2$ of the total volume in the first $8\,hours$; administer the remaining $1/2$ over the next $16\,hours$.     * Monitoring: Urine output (UOP) must be $\geq 30 - 50\,mL/hr$ or $\geq 0.5\,mL/kg/hr$.
• Burn Prioritization: Follow ABCs. Assess the airway for inhalation injury. High risk for Hypovolemic Shock due to capillary leak and fluid shifts. Burns induce a hypermetabolic state.
• Steven Johnson Syndrome (SJS):     * Cause: Severe drug interactions.     * Symptoms: Skin sloughing, painful rash resembling burns.     * Management: Stop the causative drug immediately.

Systematic Recognition of Medical and Neoplastic Conditions

• Gastrointestinal and Metabolic Disorders:     * GERD: Complications include Esophagitis, Strictures, and Barretts esophagus. Preventative measures and medication are required.     * Gout: Treated with Allopurinol (prevention) and Colchicine (acute attacks; watch for GI toxicity). Advise patients to avoid high-purine foods and alcohol.     * Pancreatitis: Complications include Hypocalcemia, ARDS, and shock. Monitoring of Amylase and Lipase is essential for diagnosis.
• Genitourinary Conditions:     * Incontinence Types: Stress (coughing, jumping), Urge (sudden need), Overflow (retention issues), and Functional (mobility issues).     * Benign Prostatic Hyperplasia (BPH): Characterized by Hesitancy, Nocturia, Weak Stream, and Incomplete emptying.     * Renal Cell Carcinoma (RCC): Classic triad of Hematuria, Flank pain, and a Palpable mass.     * End-Stage Renal Disease (ESRD): Managed via Hemodialysis or Transplant. Risks include fluid overload and Hyperkalemia.
• Musculoskeletal and Oncology:     * Osteoporosis: Risks include age, being female, low Ca and Vit D, smoking, sedentary lifestyle, and steroids/estrogen changes.     * Osteomyelitis: Local infection characterized by NWB (Non-Weight Bearing) and elevated WBC.     * Osteosarcoma: Progressive deep pain, rare fever, often with normal labs.     * Breast Cancer: Risks include age, genetics, early menacrne, late menopause, and hormone therapy.